ORIC PHARMACEUTICALS, INC. Shares Issued, Price Per Share
ORIC PHARMACEUTICALS, INC. (ORIC) had Shares Issued, Price Per Share of $6.50 per share as of 2025-05-23, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Equity
us-gaap:SharesIssuedPricePerShare · last filed 2026-08-03
- 2025-05-23: Shares Issued, Price Per Share $6.50.
- 2024-01-22: Shares Issued, Price Per Share $10.00.
- 2024-01-20: Shares Issued, Price Per Share $10.00.
- 2023-06-24: Shares Issued, Price Per Share $7.00.
| Period end | Shares Issued, Price Per Share |
|---|---|
| 2025-05-23 | $6.50 10-Q · filed 2026-08-03 |
| 2024-01-22 | $10.00 10-K · filed 2024-03-11 |
| 2024-01-20 | $10.00 10-K · filed 2026-02-23 |
| 2023-06-24 | $7.00 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |